Add to Google   Google Reader

Zoledronic acid protects bone in prostate cancer: the drug reduced the risk of skeletal complications in patients receiving androgen-deprivation therapy.: An article from: Internal Medicine News


 
Zoledronic acid protects bone in prostate cancer: the drug reduced the risk of skeletal complications in patients receiving androgen-deprivation therapy.: An article from: Internal Medicine News
Click For Larger Image
Written By: Jane Salodof MacNeil
Customer Rating: [ not yet rated ]   Reviews   Send to a Friend

List Price: $5.95

Our Price: $5.95

Availability: Available for download now. *Eligible orders over $25 ship free.

 
Buy it now at Amazon.com!   Buy it now at Amazon.com!


YahooFurldel.icio.usDiggSimpyStumbleUpon
Video Product Reviews
View Video Reviews

Editorial Reviews
This digital document is an article from Internal Medicine News, published by Thomson Gale on June 1, 2006. The length of the article is 886 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Zoledronic acid protects bone in prostate cancer: the drug reduced the risk of skeletal complications in patients receiving androgen-deprivation therapy.
Author: Jane Salodof MacNeil
Publication: Internal Medicine News (Magazine/Journal)
Date: June 1, 2006
Publisher: Thomson Gale
Volume: 39 Issue: 11 Page: 42(1)

Distributed by Thomson Gale
Buy it now at Amazon.com!   Buy it now at Amazon.com!


Bookmark this page:  YahooFurldel.icio.usDiggSimpyStumbleUpon


Payment Methods We Accept

Sponsored Ads





In Association with Amazon.com